[1] |
Lillehei RC, Idezuki Y, Feemster JA, et al. Transplantation of stomach, intestine, and pancreas: experimental and clinical observations[J]. Surgery, 1967, 62(4): 721-741. http://www.ncbi.nlm.nih.gov/pubmed/4862242
|
[2] |
Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends[J]. Am J Transplant, 2015, 15(1): 210-219. DOI: 10.1111/ajt.12979.
|
[3] |
吴国生.临床活体小肠移植国内外研究进展[J/CD].中华结直肠疾病电子杂志, 2013, 2 (5): 221-223. DOI: 10.3877/cma.j.issn.2095-3224.2013. 05.03.
Wu GS. Advances inliving-related small intestinal transplantation[J/CD]. Chin J Colorectal Dis(Electr Edit), 2013, 2 (5): 221-223. DOI: 10.3877/cma.j.issn. 2095-3224.2013.05.03.
|
[4] |
李元新.小肠移植发展现状、困惑与挑战[J].器官移植, 2016, 7(1): 8-13. DOI: 10.3969/j.issn.1674-7445.2016.01.002.
Li YX. Development status, confusion and challenge of small bowel transplantation[J].Organ Transplant, 2016, 7(1): 8-13. DOI: 10.3969/j.issn.1674-7445.2016.01.002.
|
[5] |
Wu GS, Cruz RJ Jr, Cai JC. Acute antibody-mediated rejection after intestinal transplantation[J]. World J Transplant, 2016, 6(4): 719-728. DOI: 10.5500/wjt.v6.i4.719.
|
[6] |
Ruiz P, Carreno M, Weppler D, et al. Immediate antibody-mediated (hyperacute) rejection in small-bowel transplantation and relationship to cross-match status and donor-specific C4d-binding antibodies: case report[J]. Transplant Proc, 2010, 42(1): 95-99. DOI: 10.1016/j.transproceed.2009.12.025.
|
[7] |
姚丹华, 李幼生, 王剑, 等.小肠移植中应用单克隆抗体免疫诱导治疗的临床疗效观察[J].中华器官移植杂志, 2013, 34(8): 486-489. DOI: 10.3760/cma.j.issn.0254-1785.2013.08.011.
Yao DH, Li YS, Wang J, et al. Clinical efficiency of monoclonal antibody induction therapy in intestinal transplantation[J]. Chin J Organ Transplant, 2013, 34(8): 486-489. DOI: 10.3760/cma.j.issn.0254-1785.2013.08.011.
|
[8] |
Borker A, Choudhary N. Rituximab[J]. Indian Pediatr, 2011, 48(8): 627-632. doi: 10.1007/s13312-011-0098-6
|
[9] |
Waddle ES, Alloway RR, Girnita A. Proteasome inhibitor treatment of antibody-mediated rejection[J]. Curr Opin Organ Transplant, 2011, 16(4): 434-438. DOI: 10.1097/MOT.0b013e328348c0e5.
|
[10] |
de Serre NP, Canioni D, Lacaille F, et al. Evaluation of C4d deposition and circulating antibody in small bowel transplantation[J]. Am J Transplant, 2008, 8(6): 1290-1296. DOI: 10.1111/j.1600-6143.2008.02221.x.
|
[11] |
Fujiwara S, Wada M, Kudo H, et al. Effectiveness of bortezomib in a patient with acute rejection associated with an elevation of donor-specific HLA antibodies after small bowel transplantation: case report[J]. Transplant Proc, 2016, 48(2): 525-527. DOI: 10.1016/j.transproceed.2015.09.073.
|
[12] |
Doǧan SM, Kılınç S, Kebapçı E, et al. Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience[J]. World J Gastroenterol, 2014, 20(25): 8215-8220. DOI: 10.3748/wjg.v20.i25.8215.
|
[13] |
Patil PB, Chougule PB, Kumar VK, et al. Recellularization of a cellular human small intestine using bone marrow stem cells[J]. Stem Cells Transl Med, 2013, 2(4): 307-315. DOI: 10.5966/sctm.2012-0108.
|
[14] |
Florescu DF, Langnas AN, Sandkovksy U. Opportunistic viral infections in intestinal transplantation[J]. Expert Rev Anti Infect Ther, 2013, 11(4): 367-381. DOI: 10.1586/eri.13.25.
|
[15] |
Avsar Y, Cicinnati VR, Kabar I, et al. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia[J]. J Clin Virol, 2014, 60(2): 177-180. DOI: 10.1016/j.jcv.2014.03.005.
|
[16] |
Florescu DF, Abu-Elmagd K, Mercer DF, et al. An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation[J]. Transplantation, 2014, 97(1): 78-82. DOI: 10.1097/TP.0b013e3182a6baa2.
|
[17] |
Tzvetanov IG, Oberholzer J, Benedetti E. Current status of living donor small bowel transplantation[J]. Curr Opin Organ Transplant, 2010, 15(3): 346-348. DOI: 10.1097/MOT.0b013e3283398fa4.
|
[18] |
Wu G, Cruz RJ. Live inclusion improves outcomes of intestinal retransplantation in adults[J].Transplantation, 2015, 99(6): 1265-1272. DOI: 10.1097/TP.0000000000000488.
|
[19] |
Filler G, Huang SH. High prevalence of renal dysfunction also after small bowel transplantation[J]. Pediatr Transplant, 2013, 17(1): 8-11. DOI: 10.1111/petr.12025.
|
[20] |
Ramos E, Hernández F, Andres A, et al. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome[J]. Pediatr Transplant, 2013, 17(5): 472-478. DOI: 10.1111/petr.12103.
|